2024-04-01 2025-03-31 2025-03-31 false 07190503 Dust In The Blood 2025-09-01 59113 false iso4217:GBP xbrli:pure 07190503 2024-03-31 07190503 2025-03-31 07190503 2024-04-01 2025-03-31 07190503 2023-03-31 07190503 2024-03-31 07190503 2023-04-01 2024-03-31 07190503 bus:SmallEntities 2024-04-01 2025-03-31 07190503 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07190503 bus:FullAccounts 2024-04-01 2025-03-31 07190503 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07190503 core:WithinOneYear 2025-03-31 07190503 core:AfterOneYear 2025-03-31 07190503 core:WithinOneYear 2024-03-31 07190503 core:AfterOneYear 2024-03-31 07190503 core:ShareCapital 2025-03-31 07190503 core:SharePremium 2025-03-31 07190503 core:RevaluationReserve 2025-03-31 07190503 core:OtherReservesSubtotal 2025-03-31 07190503 core:RetainedEarningsAccumulatedLosses 2025-03-31 07190503 core:ShareCapital 2024-03-31 07190503 core:SharePremium 2024-03-31 07190503 core:RevaluationReserve 2024-03-31 07190503 core:OtherReservesSubtotal 2024-03-31 07190503 core:RetainedEarningsAccumulatedLosses 2024-03-31 07190503 core:LandBuildings 2025-03-31 07190503 core:PlantMachinery 2025-03-31 07190503 core:Vehicles 2025-03-31 07190503 core:FurnitureFittings 2025-03-31 07190503 core:OfficeEquipment 2025-03-31 07190503 core:NetGoodwill 2025-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 07190503 core:ListedExchangeTraded 2025-03-31 07190503 core:UnlistedNon-exchangeTraded 2025-03-31 07190503 core:LandBuildings 2024-03-31 07190503 core:PlantMachinery 2024-03-31 07190503 core:Vehicles 2024-03-31 07190503 core:FurnitureFittings 2024-03-31 07190503 core:OfficeEquipment 2024-03-31 07190503 core:NetGoodwill 2024-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 07190503 core:ListedExchangeTraded 2024-03-31 07190503 core:UnlistedNon-exchangeTraded 2024-03-31 07190503 core:LandBuildings 2024-04-01 2025-03-31 07190503 core:PlantMachinery 2024-04-01 2025-03-31 07190503 core:Vehicles 2024-04-01 2025-03-31 07190503 core:FurnitureFittings 2024-04-01 2025-03-31 07190503 core:OfficeEquipment 2024-04-01 2025-03-31 07190503 core:NetGoodwill 2024-04-01 2025-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 07190503 core:ListedExchangeTraded 2024-04-01 2025-03-31 07190503 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 07190503 core:MoreThanFiveYears 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments 2025-03-31 07190503 core:Non-currentFinancialInstruments 2024-03-31 07190503 dpl:CostSales 2024-04-01 2025-03-31 07190503 dpl:DistributionCosts 2024-04-01 2025-03-31 07190503 core:LandBuildings 2024-04-01 2025-03-31 07190503 core:PlantMachinery 2024-04-01 2025-03-31 07190503 core:Vehicles 2024-04-01 2025-03-31 07190503 core:FurnitureFittings 2024-04-01 2025-03-31 07190503 core:OfficeEquipment 2024-04-01 2025-03-31 07190503 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 07190503 core:NetGoodwill 2024-04-01 2025-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 07190503 dpl:GroupUndertakings 2024-04-01 2025-03-31 07190503 dpl:ParticipatingInterests 2024-04-01 2025-03-31 07190503 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 07190503 core:ListedExchangeTraded 2024-04-01 2025-03-31 07190503 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 07190503 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 07190503 dpl:CostSales 2023-04-01 2024-03-31 07190503 dpl:DistributionCosts 2023-04-01 2024-03-31 07190503 core:LandBuildings 2023-04-01 2024-03-31 07190503 core:PlantMachinery 2023-04-01 2024-03-31 07190503 core:Vehicles 2023-04-01 2024-03-31 07190503 core:FurnitureFittings 2023-04-01 2024-03-31 07190503 core:OfficeEquipment 2023-04-01 2024-03-31 07190503 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 07190503 core:NetGoodwill 2023-04-01 2024-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 07190503 dpl:GroupUndertakings 2023-04-01 2024-03-31 07190503 dpl:ParticipatingInterests 2023-04-01 2024-03-31 07190503 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 07190503 core:ListedExchangeTraded 2023-04-01 2024-03-31 07190503 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 07190503 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 07190503 core:NetGoodwill 2025-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 07190503 core:LandBuildings 2025-03-31 07190503 core:PlantMachinery 2025-03-31 07190503 core:Vehicles 2025-03-31 07190503 core:FurnitureFittings 2025-03-31 07190503 core:OfficeEquipment 2025-03-31 07190503 core:AfterOneYear 2025-03-31 07190503 core:WithinOneYear 2025-03-31 07190503 core:ListedExchangeTraded 2025-03-31 07190503 core:UnlistedNon-exchangeTraded 2025-03-31 07190503 core:ShareCapital 2025-03-31 07190503 core:SharePremium 2025-03-31 07190503 core:RevaluationReserve 2025-03-31 07190503 core:OtherReservesSubtotal 2025-03-31 07190503 core:RetainedEarningsAccumulatedLosses 2025-03-31 07190503 core:NetGoodwill 2024-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 07190503 core:LandBuildings 2024-03-31 07190503 core:PlantMachinery 2024-03-31 07190503 core:Vehicles 2024-03-31 07190503 core:FurnitureFittings 2024-03-31 07190503 core:OfficeEquipment 2024-03-31 07190503 core:AfterOneYear 2024-03-31 07190503 core:WithinOneYear 2024-03-31 07190503 core:ListedExchangeTraded 2024-03-31 07190503 core:UnlistedNon-exchangeTraded 2024-03-31 07190503 core:ShareCapital 2024-03-31 07190503 core:SharePremium 2024-03-31 07190503 core:RevaluationReserve 2024-03-31 07190503 core:OtherReservesSubtotal 2024-03-31 07190503 core:RetainedEarningsAccumulatedLosses 2024-03-31 07190503 core:NetGoodwill 2023-03-31 07190503 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 07190503 core:LandBuildings 2023-03-31 07190503 core:PlantMachinery 2023-03-31 07190503 core:Vehicles 2023-03-31 07190503 core:FurnitureFittings 2023-03-31 07190503 core:OfficeEquipment 2023-03-31 07190503 core:AfterOneYear 2023-03-31 07190503 core:WithinOneYear 2023-03-31 07190503 core:ListedExchangeTraded 2023-03-31 07190503 core:UnlistedNon-exchangeTraded 2023-03-31 07190503 core:ShareCapital 2023-03-31 07190503 core:SharePremium 2023-03-31 07190503 core:RevaluationReserve 2023-03-31 07190503 core:OtherReservesSubtotal 2023-03-31 07190503 core:RetainedEarningsAccumulatedLosses 2023-03-31 07190503 core:AfterOneYear 2024-04-01 2025-03-31 07190503 core:WithinOneYear 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 07190503 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 07190503 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 07190503 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 07190503 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 07190503 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 07190503 bus:Director1 2024-04-01 2025-03-31

Dust In The Blood

Registered Number
07190503
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Dust In The Blood
Company Information
for the year from 1 April 2024 to 31 March 2025

Director | O'Neill, Lesley Clare

Registered Address | The Station
| 77 Canal Road
| Leeds
| LS12 2LX

Registered Number | 07190503 (England and Wales)

Dust In The Blood
Balance Sheet as at
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors | 3 | 900 |  |  |  | 800 |  |
Cash at bank and on hand |  | 496,682 |  |  |  | 407,545 |  |
|  | 497,582 |  |  |  | 408,345 |  |
Creditors amounts falling due within one year | 4 | (37,817) |  |  |  | (35,310) |  |
Net current assets (liabilities) |  |  |  | 459,765 |  |  |  | 373,035
Total assets less current liabilities |  |  |  | 459,765 |  |  |  | 373,035
Net assets |  |  |  | 459,765 |  |  |  | 373,035
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 459,665 |  |  |  | 372,935
Shareholders' funds |  |  |  | 459,765 |  |  |  | 373,035

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 1 September 2025, and are signed on its behalf by:
O'Neill, Lesley Clare Director Registered Company No. 07190503

Dust In The Blood
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Revenue from sale of goods
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which they relate.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 0 |  | 0

3. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Prepayments and accrued income | 900 |  | 800
| Total | 900 |  | 800

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 32,492 |  | 30,992
| Other creditors | 1,825 |  | 818
| Accrued liabilities and deferred income | 3,500 |  | 3,500
| Total | 37,817 |  | 35,310